CDSCO License for External transcutaneous cardiac pacemaker
Medical Device Information
Intended Use
An external transcutaneous cardiac pacemaker (noninvasive) is a device used to supply a periodic electrical pulse intended to pace the heart. The pulse from the device is usually applied to the surface of the chest through electrodes such as defibrillator paddles.

Comprehensive Guide to CDSCO Licensing for External Transcutaneous Cardiac Pacemaker (Class C)
As seasoned regulatory consultants with over 25 years of experience and having supported 500+ medical device companies, we understand how critical it is to secure the appropriate CDSCO license to market your external transcutaneous cardiac pacemaker in India. This device, classified as Class C under the cardiovascular category, plays a vital role in noninvasive cardiac pacing by delivering periodic electrical pulses through chest surface electrodes like defibrillator paddles. Understanding the regulatory framework, timelines, costs, and documentation is essential for a smooth approval process.
CDSCO Regulatory Framework for External Transcutaneous Cardiac Pacemakers
The Central Drugs Standard Control Organization (CDSCO) governs the import, manufacture, and sale of medical devices in India under the Medical Device Rules, 2017. Since your device falls under Class C, it is subject to stringent regulatory controls administered by the Central Licensing Authority. The relevant notification for this device is 29/Misc./03/2020-DC (159), dated 26.7.2021, which confirms its classification and regulatory requirements.
Risk Classification and License Requirements
The external transcutaneous cardiac pacemaker is a Class C device due to its moderate to high risk profile associated with cardiovascular function. Accordingly, manufacturers and importers must secure an MD9 manufacturing license or MD15 import license respectively, issued by the Central Licensing Authority.
- Manufacturing (MD9 License): Required if you plan to manufacture locally.
- Import (MD15 License): Required if the device is imported into India.
For detailed device classification, visit our Medical Device Classification resource.
Manufacturing License Process for Class C Devices (MD9)
The manufacturing license under Form MD7 (MD9 license) involves a multi-step process:
- Test License (MD13): Obtain a test license to initiate product testing, which generally takes 1.5 to 2 months.
- Product Testing: Conduct mandatory testing at CDSCO-approved government laboratories to validate device safety and performance. Refer to the list of testing laboratories.
- Document Preparation: Compile comprehensive documentation, including Device Master File, Plant Master File, risk management files, and essential principles checklist.
- License Application (MD7): Submit your manufacturing license application through the CDSCO MD Online Portal.
- Audit by CDSCO Inspectors: Undergo a detailed audit of your manufacturing facility and quality systems.
- Query Resolution: Address any queries raised by the CDSCO or auditors promptly.
- Grant of License (MD9 Form): Receive the manufacturing license upon successful completion.
For an in-depth understanding of the MD9 license process, see our MD9 License Guide.
Manufacturing License Documents Required
To streamline your application, ensure all the following documents are prepared meticulously:
- Company Constitution Documents (Incorporation Certificate, Memorandum of Association)
- Proof of Ownership or Lease of Manufacturing Premises
- Technical Staff Qualification and Experience Details
- Fire NOC and Pollution Control NOC
- Device Master File (DMF) detailing design, materials, components, and manufacturing processes (Device Master File Guide)
- Plant Master File (PMF) outlining facility layout, equipment, and quality controls (Plant Master File Guide)
- Essential Principles Compliance Checklist
- Risk Management File demonstrating hazard identification and mitigation (Risk Management)
- Test Reports from government-approved labs
- Labels and Instructions for Use (IFU)
- Quality Management System (QMS) Documentation compliant with ISO 13485:2016
Import License Process for Class C Devices (MD15)
If you are importing the external transcutaneous cardiac pacemaker, the import license process under Form MD14 (MD15 license) is as follows:
- Document Preparation: Assemble all required documents including manufacturing license of the foreign manufacturer, Free Sale Certificate, ISO 13485:2016, CE Certificate, Device and Plant Master Files.
- License Application Submission: File your application on the CDSCO MD Online Portal.
- Query Response: Address any clarifications requested by CDSCO promptly.
- Grant of License (MD15 Form): Receive the import license after final approval.
Refer to our detailed Import License Guide for further insights.
Import License Documents Required
- Valid Manufacturing License of the foreign manufacturer
- Free Sale Certificate or equivalent from country of origin
- ISO 13485:2016 certification
- CE Certificate or other relevant international certification
- Device Master File
- Plant Master File
- Wholesale License (if applicable)
- Company Constitution Documents
Timeline and Processing Duration
Process Step | Approximate Duration |
---|---|
Test License (MD13) | 1.5 to 2 months |
Product Testing | 1 to 1.5 months |
Document Preparation | 1 month |
License Application Review | 1 to 2 months |
Audit and Query Resolution | 1 to 1.5 months |
Total for MD9 License | 4 to 5 months |
Total for MD15 Import License | 5 to 6 months |
Government Fees and Costs
- MD9 Manufacturing License: Rs. 50,000 per application + Rs. 1,000 per product
- MD15 Import License:
- Class C devices: 1,500 per product
Note that these fees are payable online via the CDSCO portal. Budget also for costs related to product testing, notified body audits, and document preparation.
Common Challenges and Solutions
- Delays in Product Testing: Testing at government-approved labs can be time-consuming due to backlog. To mitigate this, schedule testing early and follow up regularly.
- Incomplete Documentation: Missing or inconsistent files often cause delays. We recommend rigorous internal audits using checklists before submission.
- Audit Non-Compliance: Facilities not meeting GMP or QMS standards fail audits. Conduct mock audits and train staff thoroughly in advance.
- Query Resolution Delays: Slow responses can stall approvals. Designate a dedicated regulatory officer to monitor and respond promptly.
Expert Consultation and Support
Navigating CDSCO regulatory requirements for a Class C device like an external transcutaneous cardiac pacemaker can be complex. Our team has successfully guided numerous manufacturers and importers through the entire process, from documentation to audit and license grant. We offer:
- Customized gap analysis of your current compliance status
- Preparation and review of Device and Plant Master Files
- Liaison with testing laboratories and notified bodies
- End-to-end application filing on the CDSCO MD Online Portal
- Training and support during audits
Getting Started with Your CDSCO License Application
- Determine Your Regulatory Path: Decide if you are manufacturing locally (MD9) or importing (MD15).
- Register on CDSCO MD Online Portal: Create your account to access all application forms and status tracking.
- Initiate Test License Application (for manufacturing): Apply for MD13 to start testing.
- Engage a Government-Approved Testing Laboratory: Early coordination can save time.
- Prepare Documentation: Use our comprehensive guides for Device Master File and Plant Master File.
- Schedule Audit with Notified Bodies: Check the list of notified bodies for Class C device audits.
- Submit Application and Monitor: Upload all documents, pay fees, and actively track application progress.
By following these practical steps and leveraging expert assistance, manufacturers and importers can confidently achieve regulatory compliance and successfully launch their external transcutaneous cardiac pacemakers in the Indian market.
For personalized support tailored to your product and business needs, contact us today to leverage our 25+ years of regulatory expertise.